Haleon (HLN) Depreciation & Amortization (CF) (2022 - 2025)
Haleon's (HLN) quarterly Depreciation & Amortization (CF) came in at $154.1 million in Q4 2025, up 26.67% on a QoQ basis from $121.6 million in Q4 2023.
Haleon (HLN) Depreciation & Amortization (CF) (2022 - 2025) Analysis & Trends
Haleon (HLN) has 3 years of Depreciation & Amortization (CF) data on file, last reported at $154.1 million in Q4 2025.
- Quarterly Depreciation & Amortization (CF) changed N/A year-over-year to $154.1 million in Q4 2025, while the trailing twelve-month figure through Jun 2026 was $154.1 million (changed N/A YoY) and the FY2025 annual result came in at $319.2 million, up 11.0% from the prior year.
- Depreciation & Amortization (CF) rose to $154.1 million in Q4 2025, from $121.6 million in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $154.1 million in Q4 2025 to a low of $96.2 million in Q4 2022.
- A 3-year average of $124.0 million and a median of $121.6 million in 2023 frame the typical range for Depreciation & Amortization (CF).
- The widest YoY moves for Depreciation & Amortization (CF): up 26.46% in 2023, down 26.46% in 2023.
- Tracing HLN's Depreciation & Amortization (CF) over 3 years: stood at $96.2 million in 2022, then increased by 26.46% to $121.6 million in 2023, then climbed by 26.67% to $154.1 million in 2025.
- The last three Depreciation & Amortization (CF) figures came in at $154.1 million (Q4 2025), $121.6 million (Q4 2023), and $96.2 million (Q4 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn | 241.00 Mn |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn | 119.00 Mn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn | 1.02 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 24.20 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 672.30 Mn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn | 171.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Alkermes | 8.20 Bn | 7.55 Bn | 397.90 Mn | 30.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 154.08 Mn |
| Dec 31, 2025 | 154.08 Mn |
| Dec 31, 2023 | 121.63 Mn |
| Dec 31, 2023 | 121.63 Mn |
| Dec 31, 2022 | 96.18 Mn |
| Dec 31, 2022 | 96.18 Mn |